<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> caused by polyglutamine-expanded ataxin-3 </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> is found in the pontine nuclei and cerebellum </plain></SENT>
<SENT sid="2" pm="."><plain>Polyglutamine-expanded ataxin-3-Q79 caused apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of cerebellar and pontine nuclei neurons by upregulating <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of pro-apoptotic Bax and activating mitochondria-mediated apoptotic cascade </plain></SENT>
<SENT sid="3" pm="."><plain>Following various cellular stresses, transcription factor p53 promotes apoptotic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> by enhancing the transcription of pro-apoptotic genes including Bax and PUMA </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, cellular and animal models of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> were used to test the hypothesis that mutant polyglutamine ataxin-3 upregulates Bax expression of cerebellar and pontine nuclei neurons by augmenting transcriptional activity of p53 </plain></SENT>
<SENT sid="5" pm="."><plain>Electrophoretic mobility shift assay (EMSA) indicated that p53 binding activity to Bax promoter sequence was significantly enhanced in cultured cerebellar neurons expressing mutant ataxin-3-Q79 and pontine nuclei and cerebellum of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> transgenic mice expressing ataxin-3-Q79 </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> level of PUMA, a p53-inducible pro-apoptotic gene, was increased in the cerebellum and pontine nuclei of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> transgenic mice and cultured cerebellar neurons expressing ataxin-3-Q79 </plain></SENT>
<SENT sid="7" pm="."><plain>Mutant polyglutamine ataxin-3 increased the protein level of active phospho-p53(Ser15) in cerebellar and pontine nuclei neurons without affecting <z:chebi fb="2" ids="33699">mRNA</z:chebi> or protein level of p53 </plain></SENT>
<SENT sid="8" pm="."><plain>Intraperitoneal administration of p53 inhibitor pifithrin-Î± significantly ameliorated neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the pontine nuclei of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> transgenic mice </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that polyglutamine-expanded ataxin-3 upregulates <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of Bax and PUMA and causes apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of affected neurons by enhancing phosphorylation and transcriptional activity of p53 </plain></SENT>
</text></document>